手术及放疗治疗足踝部弥漫性色素沉着绒毛结节性滑膜炎
Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy.
作者信息
Lee M, Mahroof S, Pringle J, Short S C, Briggs T W R, Cannon S R
机构信息
Bone and Soft Tissue Tumour Unit, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, London, UK.
出版信息
Int Orthop. 2005 Dec;29(6):403-5. doi: 10.1007/s00264-005-0004-8.
Abstract
We followed up seven patients with histologically confirmed diffuse pigmented villonodular synovitis in a prospective study between 1992 ans 2001. The mean age at diagnosis was 30.7 years. The patients underwent synovectomy, followed by radiotherapy with a total dose of 35 Gy in 20 fractions. In all cases, the excision was considered incomplete when examined histologically. At an average follow up of 24 (18-36) months, six patients reported better function and reduced levels of pain. One patient remained symptomatic but did not have a recurrence. We conclude that a combined approach to a primary pigmented villonodular synovitis of the foot and ankle may reduce the risk of recurrence without functional impairment.
摘要
在1992年至2001年的一项前瞻性研究中，我们对7例经组织学确诊为弥漫性色素沉着绒毛结节性滑膜炎的患者进行了随访。诊断时的平均年龄为30.7岁。患者接受了滑膜切除术，随后进行放疗，总剂量为35 Gy，分20次给予。在所有病例中，组织学检查时切除均被认为不完全。平均随访24（18 - 36）个月时，6例患者报告功能改善且疼痛程度减轻。1例患者仍有症状，但未复发。我们得出结论，对于足踝原发性色素沉着绒毛结节性滑膜炎采用联合治疗方法可能会降低复发风险且不造成功能损害。
相似文献
1
Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy.
Int Orthop. 2005 Dec;29(6):403-5. doi: 10.1007/s00264-005-0004-8.
2
Pigmented villonodular synovitis of the foot and ankle: a 12-year experience from a tertiary orthopedic Oncology Unit.
J Foot Ankle Surg. 2004 Nov-Dec;43(6):407-11. doi: 10.1053/j.jfas.2004.09.002.
3
Results and recurrence of pigmented villonodular synovitis of the ankle: does diffuse PVNS with extra-articular extension tend to recur more often?
Knee Surg Sports Traumatol Arthrosc. 2018 Oct;26(10):3118-3123. doi: 10.1007/s00167-017-4488-8. Epub 2017 Apr 7.
4
Irradiation as adjunctive treatment of diffuse pigmented villonodular synovitis of the foot and ankle prior to tumor surgical excision.
Med Hypotheses. 2003 Aug;61(2):229-30. doi: 10.1016/s0306-9877(03)00149-x.
5
Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis.
J Bone Joint Surg Am. 2008 Feb;90(2):326-8. doi: 10.2106/JBJS.G.00441.
6
Diffuse pigmented villonodular synovitis: preliminary results with intralesional resection and p32 synoviorthesis.
Clin Orthop Relat Res. 2007 Jan;454:186-91. doi: 10.1097/01.blo.0000229345.57092.a2.
7
Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee.
Arthroscopy. 2001 May;17(5):527-31. doi: 10.1053/jars.2001.24068.
8
[Postoperative radiotherapy of a benign tumor of the ankle].
Cancer Radiother. 1999 May-Jun;3(3):242-4. doi: 10.1016/s1278-3218(99)80058-4.
9
Pigmented villonodular synovitis of the ankle-radiation therapy as a primary treatment to reduce recurrence: a case report with 8-year follow-up.
J Foot Ankle Surg. 2011 Jan-Feb;50(1):108-16. doi: 10.1053/j.jfas.2010.10.001.
10
[Arthroscopic treatment of pigmented villonodular synovitis of the ankle: a clinical case report and review].
Medwave. 2019 May 27;19(4):e7641. doi: 10.5867/medwave.2019.04.7641.
引用本文的文献
1
Distribution Patterns of Benign and Malignant Bone and Soft Tissue Tumors and Tumor-like lesions in the Hindfoot and Ankle: A 12.5-year Analysis.
In Vivo. 2024 Sep-Oct;38(5):2383-2389. doi: 10.21873/invivo.13705.
2
Multiportal Arthroscopy-assisted Surgical Resection of Diffuse-type Tenosynovial Giant Cell Tumors in the Ankle Joint Yields Favorable Clinical Outcomes: A Retrospective Study.
Orthop Surg. 2024 Nov;16(11):2680-2687. doi: 10.1111/os.14180. Epub 2024 Aug 12.
3
Pigmented Villonodular Synovitis of Ankle Joint - A Case Report.
J Orthop Case Rep. 2023 Nov;13(11):133-136. doi: 10.13107/jocr.2023.v13.i11.4034.
4
Diffuse Tenosynovial Giant Cell Tumor Encircling the First Metatarsal Bone Remodeling after Resection. A Case Report.
J Orthop Case Rep. 2023 Jun;13(6):89-93. doi: 10.13107/jocr.2023.v13.i06.3708.
5
Pigmented Villonodular Synovitis of Flexor Hallusis Longus, Flexor Digitorum Longus, Tibialis Posterior: A Rare Case Report.
Cureus. 2022 Apr 29;14(4):e24595. doi: 10.7759/cureus.24595. eCollection 2022 Apr.
6
Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis.
PLoS One. 2021 Dec 2;16(12):e0260795. doi: 10.1371/journal.pone.0260795. eCollection 2021.
7
Radiosynoviorthesis after Surgery in the Treatment of Patients with Ankle Pigmented Villonodular Synovitis: A Case Series.
J Clin Med. 2020 Feb 22;9(2):597. doi: 10.3390/jcm9020597.
8
[Inflammatory changes of the foot].
Radiologe. 2018 May;58(5):433-441. doi: 10.1007/s00117-018-0364-x.
9
Necessity of adjuvant postoperative radiotherapy for diffuse pigmented villonodular synovitis of the knee: A case report and literature review.
Medicine (Baltimore). 2018 Jan;97(3):e9637. doi: 10.1097/MD.0000000000009637.
10
Surgical treatment for diffused-type giant cell tumor (pigmented villonodular synovitis) about the ankle joint.
BMC Musculoskelet Disord. 2017 Nov 14;18(1):450. doi: 10.1186/s12891-017-1824-6.
本文引用的文献
1
Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee.
Arthroscopy. 2001 May;17(5):527-31. doi: 10.1053/jars.2001.24068.
2
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
J Clin Oncol. 2000 Jun;18(12):2435-43. doi: 10.1200/JCO.2000.18.12.2435.
3
Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.
Radiother Oncol. 1999 Dec;53(3):205-8. doi: 10.1016/s0167-8140(99)00118-8.
4
Second malignancies after Hodgkin's disease: the Munich experience.
Ann Hematol. 1999 Dec;78(12):544-54. doi: 10.1007/s002770050556.
5
Second malignancies following pure seminoma.
Oncology. 2000;58(1):75-82. doi: 10.1159/000012082.
6
Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.
Cancer. 2000 Jan 15;88(2):398-406. doi: 10.1002/(sici)1097-0142(20000115)88:2<398::aid-cncr22>3.0.co;2-v.
7
Radiobiological mechanisms of anti-inflammatory radiotherapy.
Radiother Oncol. 1999 Jun;51(3):197-203. doi: 10.1016/s0167-8140(99)00066-3.
8
Mechanisms of the anti-inflammatory activity of low-dose radiation therapy.
Int J Radiat Biol. 1998 Sep;74(3):367-78. doi: 10.1080/095530098141500.
9
Therapeutic effects of low radiation doses.
Strahlenther Onkol. 1994 Jan;170(1):1-12.
10
Outcome following radiation treatment for high-risk pigmented villonodular synovitis.
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):777-86. doi: 10.1016/0360-3016(95)00514-Y.
Zotero 插件